Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Outcome Measure Requirements for Organ Procurement Organizations

by the Centers for Medicare & Medicaid Services on 12/02/2020.

This final rule revises the Organ Procurement Organizations (OPOs) Conditions for Coverage (CfCs) to increase donation rates and organ transplantation rates by replacing the current outcome measures with new transparent, reliable, and objective outcome measures and increasing competition for open donation service areas (DSAs).

Medicare Program; Specialty Care Models To Improve Quality of Care and Reduce Expenditures; Correction

by the Centers for Medicare & Medicaid Services on 12/02/2020.

This document corrects technical and typographical errors that appeared in the final rule published in the September 29, 2020 Federal Register entitled ``Medicare Program; Specialty Care Models To Improve Quality of Care and Reduce Expenditures,'' which established the Radiation Oncology Model and the End-Stage Renal Disease Treatment Choices...

Supplemental Evidence and Data Request on Transitions of Care From Pediatric to Adult Services for Children With Special Healthcare Needs

by the Agency for Healthcare Research and Quality on 12/02/2020.

The Agency for Healthcare Research and Quality (AHRQ) is seeking scientific information submissions from the public. Scientific information is being solicited to inform our review on Transitions of Care from Pediatric to Adult Services for Children with Special Healthcare Needs, which is currently being conducted by the AHRQ's Evidence-based...

Supplemental Evidence and Data Request on Living Systematic Review on Plant-Based Treatment for Chronic Pain

by the Agency for Healthcare Research and Quality on 12/02/2020.

The Agency for Healthcare Research and Quality (AHRQ) is seeking scientific information submissions from the public. Scientific information is being solicited to inform our Living Systematic Review on Plant-Based Treatment for Chronic Pain, which is currently being conducted by the AHRQ's Evidence-based Practice Centers (EPC) Program. Access to...

Notice of Closed Meeting

by the Centers for Disease Control and Prevention on 12/02/2020.

Canned Pacific Salmon Deviating From Identity Standard; Amendment of Temporary Marketing Permit

by the Food and Drug Administration on 12/02/2020.

The Food and Drug Administration (FDA) is amending Bumble Bee Seafoods Inc.'s temporary permit to market test canned skinless and boneless chunk salmon packed in water that contains sodium tripolyphosphate to inhibit protein curd formation during retorting. The temporary permit is amended to add an additional manufacturing location. This...

Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals

by the Food and Drug Administration on 12/02/2020.

The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

Request for Information: HIV National Strategic Plan 2021-2025 Available for Public Comment

by the Health and Human Services Department on 12/02/2020.

The Department of Health and Human Services' (HHS) Office of Infectious Disease and HIV/AIDS Policy (OIDP) in the Office of the Assistant Secretary for Health (OASH) announces the draft HIV National Strategic Plan: A Roadmap to End the HIV Epidemic (2021-2025) (HIV Plan) available for public comment. The draft HIV Plan may be reviewed at...

National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting

by the National Institutes of Health on 12/02/2020.

Advisory Committee on Immunization Practices (ACIP)

by the Centers for Disease Control and Prevention on 12/02/2020.

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. The meeting will be webcast live via the World Wide Web.

Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations

by the Centers for Medicare & Medicaid Services on 12/02/2020.

This final rule addresses any undue regulatory impact and burden of the physician self-referral law. This final rule is being issued in conjunction with the Centers for Medicare & Medicaid Services' (CMS) Patients over Paperwork initiative and the Department of Health and Human Services' (the Department or HHS) Regulatory Sprint to Coordinated...

Agency Information Collection Activities; Proposed Collection; Comment Request; Infant Formula Requirements

by the Food and Drug Administration on 12/02/2020.

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including...

Medicare and State Health Care Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements

by the Health and Human Services Department on 12/02/2020.

This final rule amends the safe harbors to the Federal anti- kickback statute by adding new safe harbors and modifying existing safe harbors that protect certain payment practices and business arrangements from sanctions under the anti-kickback statute. This rule is issued in conjunction with the Department of Health and Human Services' (HHS's)...